HealthTronics denies misleading over OssaTron
This article was originally published in Clinica
Executive Summary
Argil Wheelock, CEO of Marietta, Georgia-based HealthTronics Surgical Services, has hit back after a number of US law firms declared their intention to launch class action shareholder suits against the firm. He said the claims - that the company had misled investors over the effectiveness and market uptake of its extracorporeal shock wave treatment device to treat heel pain - were without merit.